Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07531173) titled 'Serotonin Norepinephrine Reuptake Inhibitors and the Risk of Serious Adverse Events' on April 9.

Study Type: Observational

Primary Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Condition: Chronic Kidney Disease

Intervention: Drug: Venlafaxine or duloxetine

Recruitment Status: Not recruiting

Date of First Enrollment: September 1, 2008

Target Sample Size: 8688

To know more, visit https://clinicaltrials.gov/study/NCT07531173

Disclaimer: Curated by HT Syndication....